Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SLC18A3 is a member of the vesicular amine transporter family. Additionally we are shipping Solute Carrier Family 18 (Vesicular Acetylcholine), Member 3 Kits (7) and and many more products for this protein.
Showing 10 out of 94 products:
Human Polyclonal SLC18A3 Primary Antibody for IEM, ICC - ABIN1526179
Wang, Guan, Ochiai, Nakai: An electron microscopic observation of the vesicular acetylcholine transporter-immunoreactive fibers in the rat dorsal raphe nucleus. in Brain research bulletin 1998
Show all 20 references for ABIN1526179
Rat (Rattus) Polyclonal SLC18A3 Primary Antibody for IHC, WB - ABIN1742304
Gallart-Palau, Tarabal, Casanovas, Sábado, Correa, Hereu, Piedrafita, Calderó, Esquerda: Neuregulin-1 is concentrated in the postsynaptic subsurface cistern of C-bouton inputs to α-motoneurons and altered during motoneuron diseases. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2014
Show all 4 references for ABIN1742304
Human Monoclonal SLC18A3 Primary Antibody for IHC, WB - ABIN1027709
Erickson, Varoqui: Molecular analysis of vesicular amine transporter function and targeting to secretory organelles. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001
Show all 2 references for ABIN1027709
PCMC expression of ADAM29 (show ADAM29 Antibodies), FLRT2 (show FLRT2 Antibodies), and SLC18A3 could be assessed as part of a routine screen to help identify individuals at risk of severe Obstructive sleep apnea in Asian populations
Expression of VAChT is increased in neuronal cell lines following upregulation of Lhx8 (show LHX8 Antibodies).
alpha-Synuclein (show SNCA Antibodies) expression in axons to the distal gut (show GUSB Antibodies) correlates closely with expression of the cholinergic marker, VAChT.
Data indicate that siRNA-mediated attenuation of vesicular acetylcholine transporter (VAChT, SLC18A3) reversed the apoptotic activity of vesamicol.
Multiple abnormalities with intellectual and developmental disability result from recurrent deletions and reciprocal duplications of 10q11.21q11.23 including CHAT and SLC18A3.
overexpressed ChAT enhanced transcription of the CHT1 (show ChT Antibodies) gene but not the VACHT gene
Mutations in the vesicular acetylcholine transporter demonstrate decreased affinity for acetylcholine and vesamicol.
The colocalisation of CHT1 (show ChT Antibodies) immunoreactivity with VAChT immunoreactivity in cholinergic enteric nerves in the human bowel thus suggests that CHT1 (show ChT Antibodies) represents another marker of cholinergic nerves.
Three non-coding SNPs were detected in SLC18A3. None demonstrated any reproducible association with late-onset AD in our samples.
An 11.2 kb transgene (named hV11.2) that spanned about 5 kb upstream of the start of VACHT translation down to the first choline acetyltransferase coding exon gave variable expression in the medial habenular nucleus of transgenic mice
Loss of VAChT expression is associated with pulmonary inflammation.
decreased VAChT levels affect synaptic vesicle biogenesis and distribution whereas a lower ACh (show FGFR3 Antibodies) content affects vesicles shape.
we conclude that VAChT overexpression is sufficient to enhance ACh (show FGFR3 Antibodies) release in the hippocampal formation
Data indicate that elimination of VAChT had only marginal consequences in striatum-related tasks and did not affect spontaneous locomotion, cocaine-induced hyperactivity, or its reward properties.
Mice with 65% knockdown of VAChT had normal prepulse inhibition and short-term habituation of startle reaction, whereas long-term habituation was disrupted.
VAChT mutant mice present preserved neuromuscular function, but altered brain cholinergic function and are hyperactive.
These results reveal the dependence of short-term plasticity on the level of VAChT expression and efficient synaptic vesicle filling.
Results indicated that VAChT mutant mice have profound cardiac remodeling and reactivation of the fetal gene program.
Residues 481-490 contain trafficking information necessary for VAChT localization, and within this region L485 and L486 are strictly necessary. Clathrin-mediated endocytosis is required for targeting to microvesicles.
Real-time RT-PCR revealed significant decreases in VAChT mRNA in the lung of sensitized and allergen challenged animals.
This gene is a member of the vesicular amine transporter family. The encoded transmembrane protein transports acetylcholine into secretory vesicles for release into the extracellular space. Acetylcholine transport utilizes a proton gradient established by a vacuolar ATPase. This gene is located within the first intron of the choline acetyltransferase gene.
, vesicular acetylcholine transporter
, solute carrier family 18 (vesicular acetylcholine), member 3
, vesicular acetylcholine transporter-like
, solute carrier family 18 (vesicular monoamine) member 3
, solute carrier family 18, member 3
, solute carrier family 18 member 3